Search News

Corporate Industry Technology Medical Updates

Ventricular Assist Device

Corporate
magAssist Shortlisted for 2025 Prix Galien USA Best Start-Up Award 2025-08-14
Medical Updates
Zhujiang Hospital Transitions from ECMO + IABP to MoyoAssist® in the Management of Cardiogenic Shock 2025-04-30
Medical Updates
Rapid Postoperative Recovery Achieved with MoyoAssist® in High-Risk Cardiac Surgery 2025-04-12
Medical Updates
High-Risk Coronary Revascularization Supported by MoyoAssist® Magnetic Levitation 2025-04-02
Industry
TCT 2024 | NyokAssist® Makes Global Debut as a Novel Interventional Ventricular Assist Device 2024-11-01
Industry
magAssist Presents MoyoAssist® at ESAO 2024, Advancing Global Dialogue in Artificial Organ Technology 2024-09-26
Medical Updates
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi 2023-08-23
Corporate
magAssist's NyokAssist™ granted Designation by the FDA as a Breakthrough Device 2023-08-17
Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17
Corporate
The Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth 2023-07-28

Tabs： percutaneous ventricular assist device, myocardial infarction, maglev artificial heart technology, end-stage respiratory failures, VA-ECMO, ESA, the application of MoyoAssist, portable ECMO, severe shortage of heart donors, Potential Unicorn,